alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 75, Number 35 (Tuesday, February 23, 2010)]
[Notices]
[Page 8114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3423]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. AA1921-167 (Third Review)]


Pressure Sensitive Plastic Tape From Italy

AGENCY: United States International Trade Commission.

ACTION: Revised schedule for the subject review.

-----------------------------------------------------------------------

DATES: Effective Date: February 16, 2010.

FOR FURTHER INFORMATION CONTACT: Edward Petronzio (202-205-3176), 
Office of Investigations, U.S. International Trade Commission, 500 E 
Street, SW., Washington, DC 20436. Hearing-impaired persons can obtain 
information on this matter by contacting the Commission's TDD terminal 
on 202-205-1810. Persons with mobility impairments who will need 
special assistance in gaining access to the Commission should contact 
the Office of the Secretary at 202-205-2000. General information 
concerning the Commission may also be obtained by accessing its 
Internet server (http://www.usitc.gov). The public record for these 
reviews may be viewed on the Commission's electronic docket (EDIS) at 
http://edis.usitc.gov.

SUPPLEMENTARY INFORMATION: On August 20, 2009, the Commission 
established a schedule for the conduct of the review (74 FR 43155, 
August 26, 2009). Due to the closure of the Federal Government for four 
days as a result of inclement weather and related disruptions, the 
Commission is issuing a revised schedule.
    The Commission's new schedule for the review is as follows: the 
closing of the record and final release of data to parties will be 
February 18, 2010, and final comments of parties will be due on 
February 22, 2010.
    For further information concerning the review see the Commission's 
notice cited above and the Commission's Rules of Practice and 
Procedure, part 201, subparts A through E (19 CFR part 201), and part 
207, subparts A and C (19 CFR part 207).

    Authority:  The review is being conducted under authority of 
title VII of the Tariff Act of 1930; this notice is published 
pursuant to section 207.21 of the Commission's rules.

    By order of the Commission.

     Issued: February 16, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 2010-3423 Filed 2-22-10; 8:45 am]
BILLING CODE P
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1768 Sodium lactate. ( a ) Sodium lactate (C3H5O3Na, CAS Reg. No. 72-17-3) is the sodium salt of lactic acid. It is prepared commercially by the neutralization of lactic acid with sodium hydroxide.
( b ) The ingredient must be of a purity suitable for its intended use.
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. This regulation does not authorize its use in infant foods and infant formulas. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as an emulsifier as defined in § 170.3(o)(8) of this chapter; a flavor enhancer as defined in § 170.3(o)(11) of this chapter; a flavoring agent or adjuvant as defined in § 170.3(o)(12) of this chapter; a humectant as defined in § 170.3(o)(16) of this chapter; and a pH control agent as defined in § 170.3(o)(23) of this chapter.
( 2 ) The ingredient is used in food at levels not to exceed current good manufacturing practice.
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[52 FR 10886, Apr. 6, 1987, as amended at 73 FR 8608, Feb. 14, 2008]
§ 1.705 What user fees are established under this subpart? ( a ) The following application fees: ( 1 ) Accreditation bodies applying for recognition are subject to an application fee for the estimated average cost of the work FDA performs in reviewing and evaluating applications for recognition of accreditation bodies.
( 2 ) Recognized accreditation bodies submitting renewal applications are subject to a renewal application fee for the estimated average cost of the work FDA performs in reviewing and evaluating renewal applications for recognition of accreditation bodies.
( 3 ) Third-party certification bodies applying for direct accreditation are subject to an application fee for the estimated average cost of the work FDA performs in reviewing and evaluating applications for direct accreditation.
( 4 ) Accredited third-party certification bodies applying for renewal of direct accreditation are subject to an application fee for the estimated average cost of the work FDA performs in reviewing and evaluating renewal applications for direct accreditation.
( b ) The following annual fees: ( 1 ) Recognized accreditation bodies are subject to an annual fee for the estimated average cost of the work FDA performs to monitor performance of recognized accreditation bodies under § 1.633.
( 2 ) Third-party certification bodies directly accredited by FDA are subject to an annual fee for the estimated average cost of the work FDA performs to monitor directly accredited third-party certification bodies under § 1.662.
( 3 ) Third-party certification bodies accredited by recognized accreditation bodies are subject to an annual fee for the estimated average cost of the work FDA performs to monitor third-party certification bodies that are accredited by a recognized accreditation body under § 1.662.
###### Editorial Note on Part 173

#### Editorial Note:

Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

#### § 173.210 Acetone.

A tolerance of 30 parts per million is established for acetone in spice oleoresins when present therein as a residue from the extraction of spice.
Exhibit 32.1


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


 In connection with the Quarterly Report of First Health Group Corp. (the
 "Company") on Form 10-Q for the period ended September 30, 2003, as filed
 with the Securities and Exchange Commission on the date hereof (the
 "Report"), I, Edward L. Wristen, Chief Executive Officer of the Company, do
 hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
 Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)  The Report fully complies with the requirements of Section 13(a)
 or 15(d) of the Securities Exchange Act of 1934; and

      (2)  The information contained in the Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.


 /s/ Edward L. Wristen

 Edward L. Wristen
 President and Chief Executive Officer
 November 12, 2003
Exhibit 32.1

                         AMCOL INTERNATIONAL CORPORATION

                   Certification of Periodic Financial Report
                       Pursuant to 18 U.S.C. Section 1350

      Pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned  officer of AMCOL  International
Corporation (the "Company")  certifies that the Quarterly Report on Form 10-Q of
the  Company  for the  quarter  ended  June 30,  2003  fully  complies  with the
requirements  of Section 13(a) or 15(d) of the  Securities  Exchange Act of 1934
and  information  contained in that Form 10-Q fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

Dated: August 12, 2003                       /s/ Lawrence E. Washow
                                             --------------------------
                                             Lawrence E. Washow
                                             Chief Executive Officer

      A signed  original of this written  statement  required by Section 906 has
been provided to AMCOL  International  Corporation and will be retained by AMCOL
International   Corporation   and  furnished  to  the  Securities  and  Exchange
Commission or it's staff upon request.
H. Res. 947

In the House of Representatives, U.S., 

July 26, 2006.

Resolved, That at any time after the adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule 

XVIII, declare the House resolved into the Committee of the 

Whole House on the state of the Union for consideration of 

the bill (H.R. 5682) to exempt from certain requirements of 

the Atomic Energy Act of 1954 a proposed nuclear agreement for cooperation with India. The first reading of the bill 

shall be dispensed with. All points of order against consideration of the bill are waived. General debate shall be confined 

to the bill and shall not exceed one hour equally divided and 

controlled by the chairman and ranking minority member of 

the Committee on International Relations. After general debate the bill shall be considered for amendment under the 

five-minute rule. The amendment in the nature of a substitute recommended by the Committee on International Relations now printed in the bill, modified by the amendment 

printed in part A of the report of the Committee on Rules 

accompanying this resolution, shall be considered as adopted 
2

•HRES 947 EH 

in the House and in the Committee of the Whole. The bill, 

as amended, shall be considered as the original bill for the 

purpose of further amendment and shall be considered as 

read. Notwithstanding clause 11 of rule XVIII, no further 

amendment to the bill, as amended, shall be in order except 

those printed in part B of the report of the Committee on 

Rules. Each such amendment may be offered only in the 

order printed in the report, may be offered only by a Member 

designated in the report, shall be considered as read, shall be 

debatable for the time specified in the report equally divided 

and controlled by the proponent and an opponent, shall not 

be subject to amendment, and shall not be subject to a demand for division of the question in the House or in the 

Committee of the Whole. All points of order against such 

amendments are waived. At the conclusion of consideration of 

the bill for amendment the Committee shall rise and report 

the bill, as amended, to the House with such further amendments as may have been adopted. The previous question shall 

be considered as ordered on the bill and amendments thereto 

to final passage without intervening motion except one motion to recommit with or without instructions. 

Attest:

Clerk.
<PAGE>

                                FIRST AMENDMENT
                                      TO
                        POWER CONTROL TECHNOLOGIES INC.
                            1995 STOCK OPTION PLAN


                  The Power Control Technologies Inc. 1995 Stock Option Plan
(the "Plan"), is hereby amended, effective as of February 12, 1997, as set
forth below.

                  1. Section 8 of the Plan is amended by restating paragraph
(h) thereof to read as follows:

         The Options are nontransferable except (1) by will or by laws of
         descent and distribution, or (2) as specifically provided below. The
         Optionee may transfer Nonqualified Stock Options to members of his or
         her Immediate Family (as defined below) or to his or her Affiliates
         (as defined below) (any such transferee, "Permitted Transferee") if
         the Optionee does not receive any consideration for the transfer.
         "Immediate Family" refers to children, grandchildren, and spouse of
         the Optionee or one or more trusts solely for the benefit of such
         family members, or partnerships in which such family members are the
         only partners. "Affiliate" refers to any person that directly, or
         indirectly through one or more intermediaries, controls, or is
         controlled by, or is under common control with, the Optionee. Options
         may be exercised during the lifetime of the Optionee, only by the
         Optionee, or by the guardian or legal representative of the Optionee
         or the Permitted Transferee as described in this Section 8(h). The
         Optionee shall give notice to the Company of any transfer hereunder
         as soon as practicable following the date of such transfer. Any such
         Permitted Transferee must agree in writing to be bound by all the
         provisions of the Option Agreement


<PAGE>


         relating to such transferred Option, and the Company must be given a
         copy of such instrument.



                  3. Section 9 of the Plan is amended by restating paragraph
(b)(8) thereof to read as follows:

         Free Standing Rights shall be transferable to the same extent and
         subject to the same conditions as set forth in Section 8(h) of Plan.


                  4. Section 11 of the Plan is amended by restating the first
paragraph thereof to read as follows:

                  The Board at any time and from time to time may suspend,
         terminate, modify or amend the Plan; provided, however, that, unless
         otherwise determined by the Board, an amendment that requires
         stockholder approval in order for the Plan to continue to comply with
         Section 162(m) of the Code or any other law, regulation or stock
         exchange requirement shall not be effective unless approved by the
         requisite vote of stockholders.


                  Except as set forth above, the Plan is hereby ratified and
confirmed in all respects.

                                       2
§ 120.7 Hazard analysis. ( a ) Each processor shall develop, or have developed for it, a written hazard analysis to determine whether there are food hazards that are reasonably likely to occur for each type of juice processed by that processor and to identify control measures that the processor can apply to control those hazards. The written hazard analysis shall consist of at least the following: ( 1 ) Identification of food hazards;
( 2 ) An evaluation of each food hazard identified to determine if the hazard is reasonably likely to occur and thus, constitutes a food hazard that must be addressed in the HACCP plan. A food hazard that is reasonably likely to occur is one for which a prudent processor would establish controls because experience, illness data, scientific reports, or other information provide a basis to conclude that there is a reasonable possibility that, in the absence of those controls, the food hazard will occur in the particular type of product being processed. This evaluation shall include an assessment of the severity of the illness or injury if the food hazard occurs;
( 3 ) Identification of the control measures that the processor can apply to control the food hazards identified as reasonably likely to occur in paragraph (a)(2) of this section;
( 4 ) Review of the current process to determine whether modifications are necessary; and
( 5 ) Identification of critical control points.
( b ) The hazard analysis shall include food hazards that can be introduced both within and outside the processing plant environment, including food hazards that can occur before, during, and after harvest. The hazard analysis shall be developed by an individual or individuals who have been trained in accordance with § 120.13 and shall be subject to the recordkeeping requirements of § 120.12.
( c ) In evaluating what food hazards are reasonably likely to occur, consideration should be given, at a minimum, to the following: ( 1 ) Microbiological contamination;
( 2 ) Parasites;
( 3 ) Chemical contamination;
( 4 ) Unlawful pesticides residues;
( 5 ) Decomposition in food where a food hazard has been associated with decomposition;
( 6 ) Natural toxins;
( 7 ) Unapproved use of food or color additives;
( 8 ) Presence of undeclared ingredients that may be allergens; and
( 9 ) Physical hazards.
( d ) Processors should evaluate product ingredients, processing procedures, packaging, storage, and intended use; facility and equipment function and design; and plant sanitation, including employee hygiene, to determine the potential effect of each on the safety of the finished food for the intended consumer.
( e ) HACCP plans for juice need not address the food hazards associated with microorganisms and microbial toxins that are controlled by the requirements of part 113 or part 114 of this chapter. A HACCP plan for such juice shall address any other food hazards that are reasonably likely to occur.
1^ 1 

I n 

1 

ijcrr- oST - '^o'a - 11 *^VO 

^ con/co^//j r ./^/f 

A ^ ji /-/pyn CU/ 0 0 ^ 

'r 

kaV ^ 

/l? 

^ Ac? 

lla.ilC,^hrMij 

H —f M_ 'd' fkf /Vif '''Aid 

/TaoAJd'-Wli^ir r 0u 

•PW"
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# TIME AND DATE: 

2 p.m., Wednesday March 17, 2010.

# PLACE: 

1155 21st St., NW., Washington, DC, 9th Floor Commission Conference Room.

# STATUS: 

Closed.

# MATTERS TO BE CONSIDERED: 

Enforcement Matters.

# CONTACT PERSON FOR MORE INFORMATION: 

Sauntia S. Warfield, 202-418-5084.

Sauntia S. Warfield, 

Assistant Secretary of the Commission.

[FR Doc. 2010-3533 Filed 2-18-10; 4:15 pm]

BILLING CODE 6351-01-P
INDICATORS OF 

HUMAN TRAFFICKING

Does the student...

• Suddenly have more material possessions?

• Defer to another person to speak for them?

• Suddenly become extremely quiet, 

reclusive, and avoid eye contact?

• Appear to be deprived of food, water, sleep, 

medical care, or other necessities?

• Have bruises or other signs of 

physical trauma?

• Have a romantic partner who is 

noticeably older? 

• Engage in unhealthy coping behaviors (i.e. 

increase in use of drugs or alcohol, etc.)?

• Seem restricted from contacting family 

or friends?

• Not seem to be in control of their 

own money?

• Lack control over a personal schedule and/

or identification or travel documents?
VICTIM-CENTERED APPROACH

Make victims feel safe and develop trust and 

rapport by:

• Explaining who you are, answer their 

questions, and address their fears and 

urgent needs.

• Being sensitive to cultural differences and 

language barriers and use an interpreter 

when needed.

• Conducting interviews in a neutral location, 

after urgent needs have been assessed. 

• Being patient and give the victim time to 

stabilize and recover.

• Engaging a victim specialist who can 

connect victims to support services.

REPORTING AND ADDITIONAL SUPPORT

Homeland Security Investigations Tip Line:

1-866-347-2423

National Human Trafficking Hotline: 

1-888-373-7888
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED August 5, 2005 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 04-20953 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus ERIC LEE EVANS, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas USDC No. 4:04-CR-29-ALL

-------------------- Before SMITH, GARZA and PRADO, Circuit Judges.
PER CURIAM: * Eric Lee Evans appeals the sentence imposed following his guilty-plea conviction for possession of a firearm by a convicted felon in violation of 18 U.S.C. §§ 922(g)(1) and 924(a)(2). Evans argues that, in light of United States v. Booker , 125 S. Ct. 738 (2005), the district court erred in sentencing him under a mandatory guidelines system and in sentencing him based upon facts that were not admitted by him or found by a jury.No. 04-20953 -2-
T he two-level adjustment to Evans’s sentence pursuant to U.S.S.G. § 2K2.1(b)(4) violated his Sixth Amendment right to a trial by jury, and the Government has not carried its burden of demonstrating that the error was harmless. See United States v. Pineiro , 410 F.3d 282, 286 (5th Cir. 2005); United States v. Akpan , 407 F.3d 360, 376-77 (5th Cir. 2005). Accordingly, Evans’s sentence is VACATED, and the case is REMANDED FOR
RESENTENCING. Because it is necessary to vacate Evans’s sentence based upon the Sixth Amendment Booker error, we do not address Evans’s argument that his sentencing pursuant to a mandatory guidelines scheme constitutes reversible error. See Akpan , 407 F.3d at 377 n.62. VACATED AND REMANDED FOR RESENTENCING.
Motion for Rehearing Granted, Relief Denied, and Supplemental Majority and

Dissenting Opinion s on Rehearing filed March 8 , 2022.

In The 

## Fourteenth Court of Appeals

NO. 14

- 19

- 00991

- CV

DHI HOLDINGS, LP , Appellant

V.

DEUTSCHE BANK NATIONAL TRUST COMPANY, AS TRUSTEE FOR MORGAN STANLEY ABS CAPITAL I INC. TRUST 2006

- HE3, MORTGAGE PASS

- THROUGH CERTIFICATES, SERIES 2006

- HE3; DEUTSCHE BANK NATIONAL TRUST COMPANY, AS TRUSTEE FOR MORGAN STANLEY ABS CAPITAL I INC. TRUST 2006

- HE3; AND SPECIAL IZED LOAN SERVICING, LLC , Appellee s

On Appeal from the 127th District Court

Harris County, Texas Trial Court Cause No. 2018

- 06668

SUPPLEMENTAL DISSENTING OPINION ON REHEARING

For the reasons stated in my dissent on original submission, I would grant the relief requested in appellant’s motion for rehearing. See DHI Holdings, LP v.

Deutsche Bank Nat ’ l Tr. Co. as Tr. for Morgan Stanley ABS Capital I Inc. Tr. 2006

-2

HE3, Mortgage Pass

- Through Certificates, Series 2006

- HE3 , No. 14

- 19

- 00991

- CV,
2021 WL 5071472, at *5 (Tex. App.

— Houston [14th Dist.] Nov. 2, 2021, no pet.

h. ) (Zimmerer, J., dissenting).

/s/ Jerry Zimmerer Justice

Panel consists of Justices Bourliot, Zimmerer, and Spain (Spain, J., Majority)

.
<PAGE>


                                                                      EXHIBIT 23



               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS



       We have issued our report dated March 31, 2001, except for Note T as to
which the date is June 25, 2001, accompanying the consolidated financial
statements included in the Form 10-KSB/A of USABancShares.com, Inc for the year
ended December 31, 2000. We hereby consent to the incorporation by reference of
said report in the Registration Statements of USABancShares.com, Inc. on Forms
S-8 (File No. 333-84135, effective July 30, 1999, and File No. 333-68955,
effective December 15, 1998).




Philadelphia, PA
February 20, 2002